The role of plasmapheresis in childhood Guillain-Barré syndrome

Mark A. Epstein, John T. Sladky

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Plasmapheresis has been advocated in the treatment of childhood Guillain-Barré syndrome under the assumption that the results of adult series can be extrapolated to children. To test this assumption, we retrospectively evaluated the medical charts of all children who were admitted to The Children's Hospital of Philadelphia between January 1984 and March 1989, with the diagnosis of Guillain-Barré syndrome. Of the 30 patients identified, 7 were excluded because they had mild disease. Of the remaining 23,9 underwent plasmapheresis and 14 served as historic control subjects. The two groups were similar with respect to age, presenting symptoms, findings on initial physical examination, and antecedent illnesses at the time of diagnosis. The mean time to recover to Grade 2 (independent ambulation) was significantly shorter in the plasmapheresis-treated group, 24.0 ± 25.4 days, compared to 60.2 ± 43.6 days in control subjects (mean ± 1 SD). Our results indicate that plasmapheresis diminishes morbidity in childhood Guillain-Barré syndrome by shortening the interval until recovery of independent ambulation.

Original languageEnglish
Pages (from-to)65-69
Number of pages5
JournalAnnals of Neurology
Volume28
Issue number1
StatePublished - Jul 1 1990

Fingerprint

Plasmapheresis
Walking
Physical Examination
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Epstein, M. A., & Sladky, J. T. (1990). The role of plasmapheresis in childhood Guillain-Barré syndrome. Annals of Neurology, 28(1), 65-69.

The role of plasmapheresis in childhood Guillain-Barré syndrome. / Epstein, Mark A.; Sladky, John T.

In: Annals of Neurology, Vol. 28, No. 1, 01.07.1990, p. 65-69.

Research output: Contribution to journalArticle

Epstein, MA & Sladky, JT 1990, 'The role of plasmapheresis in childhood Guillain-Barré syndrome', Annals of Neurology, vol. 28, no. 1, pp. 65-69.
Epstein, Mark A. ; Sladky, John T. / The role of plasmapheresis in childhood Guillain-Barré syndrome. In: Annals of Neurology. 1990 ; Vol. 28, No. 1. pp. 65-69.
@article{92a72a083bc94690b39272c128e92880,
title = "The role of plasmapheresis in childhood Guillain-Barr{\'e} syndrome",
abstract = "Plasmapheresis has been advocated in the treatment of childhood Guillain-Barr{\'e} syndrome under the assumption that the results of adult series can be extrapolated to children. To test this assumption, we retrospectively evaluated the medical charts of all children who were admitted to The Children's Hospital of Philadelphia between January 1984 and March 1989, with the diagnosis of Guillain-Barr{\'e} syndrome. Of the 30 patients identified, 7 were excluded because they had mild disease. Of the remaining 23,9 underwent plasmapheresis and 14 served as historic control subjects. The two groups were similar with respect to age, presenting symptoms, findings on initial physical examination, and antecedent illnesses at the time of diagnosis. The mean time to recover to Grade 2 (independent ambulation) was significantly shorter in the plasmapheresis-treated group, 24.0 ± 25.4 days, compared to 60.2 ± 43.6 days in control subjects (mean ± 1 SD). Our results indicate that plasmapheresis diminishes morbidity in childhood Guillain-Barr{\'e} syndrome by shortening the interval until recovery of independent ambulation.",
author = "Epstein, {Mark A.} and Sladky, {John T.}",
year = "1990",
month = "7",
day = "1",
language = "English",
volume = "28",
pages = "65--69",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - The role of plasmapheresis in childhood Guillain-Barré syndrome

AU - Epstein, Mark A.

AU - Sladky, John T.

PY - 1990/7/1

Y1 - 1990/7/1

N2 - Plasmapheresis has been advocated in the treatment of childhood Guillain-Barré syndrome under the assumption that the results of adult series can be extrapolated to children. To test this assumption, we retrospectively evaluated the medical charts of all children who were admitted to The Children's Hospital of Philadelphia between January 1984 and March 1989, with the diagnosis of Guillain-Barré syndrome. Of the 30 patients identified, 7 were excluded because they had mild disease. Of the remaining 23,9 underwent plasmapheresis and 14 served as historic control subjects. The two groups were similar with respect to age, presenting symptoms, findings on initial physical examination, and antecedent illnesses at the time of diagnosis. The mean time to recover to Grade 2 (independent ambulation) was significantly shorter in the plasmapheresis-treated group, 24.0 ± 25.4 days, compared to 60.2 ± 43.6 days in control subjects (mean ± 1 SD). Our results indicate that plasmapheresis diminishes morbidity in childhood Guillain-Barré syndrome by shortening the interval until recovery of independent ambulation.

AB - Plasmapheresis has been advocated in the treatment of childhood Guillain-Barré syndrome under the assumption that the results of adult series can be extrapolated to children. To test this assumption, we retrospectively evaluated the medical charts of all children who were admitted to The Children's Hospital of Philadelphia between January 1984 and March 1989, with the diagnosis of Guillain-Barré syndrome. Of the 30 patients identified, 7 were excluded because they had mild disease. Of the remaining 23,9 underwent plasmapheresis and 14 served as historic control subjects. The two groups were similar with respect to age, presenting symptoms, findings on initial physical examination, and antecedent illnesses at the time of diagnosis. The mean time to recover to Grade 2 (independent ambulation) was significantly shorter in the plasmapheresis-treated group, 24.0 ± 25.4 days, compared to 60.2 ± 43.6 days in control subjects (mean ± 1 SD). Our results indicate that plasmapheresis diminishes morbidity in childhood Guillain-Barré syndrome by shortening the interval until recovery of independent ambulation.

UR - http://www.scopus.com/inward/record.url?scp=0025301967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025301967&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 65

EP - 69

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -